OptumRx To Be ‘Competitive Force’ In PBM Industry With Catamaran Buy
This article was originally published in The Pink Sheet Daily
The merger of UnitedHealth Group’s pharmacy benefit manager OptumRx with Catamaran could give the combined firm greater pricing leverage as it becomes one of the industry's giants, along with CVS Health’s Caremark and Express Scripts.
You may also be interested in...
There is a tremendous opportunity to use available data to improve health care, EY concludes, but life sciences companies must contend with siloed information and access issues, as well as shifts in who holds the most valuable data.
The drug store chain will purchase EnvisionRx, which serves over 21 million members and expects to manage 145 million pharmacy claims in 2015, for $2 billion in cash and stock.
The insurer is considering strategic options for its internal PBM, which manages more than 300 million drug claims for more than 9 million individuals, mainly in the Medicare space.